Sign In
16 Sep 2016 13:44
16 September 2016
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Change of registered holding of Director's shares
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that Colin Nicholl, non-executive Chairman of the Company, has transferred 500,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") from the Company's employee share dealing account at N+1 Singer to his account at Schroder & Co. Limited.
There has been no change to Mr Nicholl's beneficial interest in the Company which remains at 4,303,559 Ordinary Shares, representing 2.4% of the issued share capital and total voting rights of the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides additional detail.
Enquiries: | |
Microsaic Systems plc Jim Ramage, CEO Bevan Metcalf, FD | +44 (0) 1483 751577 |
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong
|
+44 (0)20 7496 3000 |
Citigate Dewe Rogerson (Financial PR) Mark Swallow, Marine Perrier | +44 (0)20 7282 2948/1068 |
About Microsaic Systems
Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.
Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.
The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.
The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.
Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).
www.microsaic.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| C J Nicholl | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR - Non-executive Chairman | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Microsaic Systems plc | ||||
b)
| LEI
| N/A | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.25p each
GB00B547ZY09
| ||||
b)
| Nature of the transaction
| Transfer of ordinary shares between accounts of the PDMR
No change in beneficial ownership
| ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transaction
| 15 September 2016 | ||||
f)
| Place of the transaction
| Outside of trading venue | ||||
Follow the stocks
